Your browser doesn't support javascript.
loading
A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas.
Munshi, Manit; Liu, Xia; Kofides, Amanda; Tsakmaklis, Nickolas; Guerrera, Maria Luisa; Hunter, Zachary R; Palomba, M Lia; Argyropoulos, Kimon V; Patterson, Christopher J; Canning, Alexa G; Meid, Kirsten; Gustine, Joshua; Branagan, Andrew R; Flynn, Catherine A; Sarosiek, Shayna; Castillo, Jorge J; Wang, Jinhua; Buhrlage, Sara J; Gray, Nathanael S; Munshi, Nikhil C; Anderson, Kenneth C; Treon, Steven P; Yang, Guang.
Afiliación
  • Munshi M; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Liu X; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Kofides A; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Tsakmaklis N; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Guerrera ML; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Hunter ZR; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Palomba ML; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Argyropoulos KV; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Patterson CJ; Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Canning AG; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Meid K; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Gustine J; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Branagan AR; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Flynn CA; Division of Hematology and Oncology, Massachusetts General Hospital, and.
  • Sarosiek S; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Castillo JJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Wang J; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Buhrlage SJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Gray NS; Bing Center for Waldenstrom's Macroglobulinemia, and.
  • Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Anderson KC; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA; and.
  • Treon SP; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA; and.
  • Yang G; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA.
Blood Adv ; 6(11): 3332-3338, 2022 06 14.
Article en En | MEDLINE | ID: mdl-35255496
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Factor 88 de Diferenciación Mieloide Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Factor 88 de Diferenciación Mieloide Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos